BMY

7 Best Cash Cow Stocks to Buy for Stable Returns

Investors seeking shelter from the market selloff through 2022 can take a look at some of the best cash cow stocks to buy.

7 Best Pharmaceutical Stocks to Buy Now

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

Best Stocks for 2022: After Two Quarters, Who Holds The Lead?

After the first two quarters of fiscal year 2022, who holds the top spot in the InvestorPlace Best Stocks for 2022 contest? Let's dive in.

Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year

BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow.

6 Stocks Hedge Funds Love in a Recession

6 stocks hedge funds love in a recession, including the top 3 holdings from Michael Burry and Leon Cooperman.

5 S&P 500 Stocks Ready to Break Out

Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out.

7 Blue-Chip Stocks With Strong Dividend Yields

Blue-Chip stocks are particularly attractive in volatile times like now. These picks include a strong dividend as well.

7 Cheap Growth Stocks That Won’t Stay That Way for Long

Investors foolishly sent these stocks into cheap territory, ignoring the near-term growth prospects that will reward them soon.

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.

The Top 10 Stocks Helping Warren Buffett Beat the Market

These Warren Buffett stocks are helping the Oracle of Omaha be a winner even in a down market. All are generating solid returns in 2022.

3 Recession-Proof Dividend Stocks to Buy

ABM Industries, Bristol-Myers and UGI are three examples of companies that saw earnings-per-share grow by high rates during the 2007 to 2009 period. All three companies have extensive dividend growth track records and each stock yields higher than what the S&P 500 is paying.

Best Stocks for 2022: Bristol-Myers Squibb Isn’t Done Growing

It's been a great year for Bristol-Myers Squibb this year, but it's not too late to jump in. BMY stock offers a respectable dividend.

7 Biotech Stocks to Buy With Key Catalysts for April

Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

7 No-Brainer Stocks to Buy for April

Start your stock scan with companies showing strong quant scores in value, growth and quality, then buy those with strong catalysts.

7 Michael Burry Stocks to Buy as ‘The Big Short’ Investor Makes Moves

The famed investor has largely cashed out of equities, but you may want to check out these 7 Michael Burry stocks still in his portfolio.

3 Top Stock Trades for This Week

Bulls seeking stock trades should focus on relative strength. Here are three stocks itching for new highs as the market sinks.

7 Drug Stocks to Consider After the Viatris Plunge

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

8 Strong Uptrend Stocks to Buy on the Next Dip

It's hard to believe, but there are uptrend stocks out there. Investors just have to look for the strength that these stocks are showing.

7 Biotech Stocks With Key Catalysts in March

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.